(R)-4-(4,7-Bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)-5-(tert-butoxy)-5-oxopentanoic acid

Catalog No. :
ACPHMB814
CAS No. :
1252799-47-5
Molecular Formula :
C27H49N3O8
Molecular Weight :
543.70

IUPAC Name:(R)-4-(4,7-bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)-5-(tert-butoxy)-5-oxopentanoic acid

(R)-4-(4,7-Bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)-5-(tert-butoxy)-5-oxopentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$976.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-4-(4,7-Bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)-5-(tert-butoxy)-5-oxopentanoic acid
IUPAC Name(R)-4-(4,7-bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)-5-(tert-butoxy)-5-oxopentanoic acid
Molecular FormulaC27H49N3O8
Molecular Weight543.70
SMILESO=C(O)CC[C@@H](N1CCN(CC(OC(C)(C)C)=O)CCN(CC(OC(C)(C)C)=O)CC1)C(OC(C)(C)C)=O
InChI KeyADHGPCATMVZKLP-HXUWFJFHSA-N
Synonym1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-(2-carboxyethyl)hexahydro-, 1,4,7-tris(1,1-dimethylethyl) ester, (α1R)-;R-NODAGA(tBu)3-OH,\;(R)-NODA-GS(TB)3;(R)-NOTA-GA-(COOt-Bu)3;(R)-4-{4,7-Bis{2-(tert-butoxy)-2-oxoethyl}-1,4,7-triazonan-1-yl}-5-(tert-butoxy)-5-oxopentanoic acid;1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-(2-carboxyethyl)hexahydro-, 1,4,7-tris(1,1-dimethylethyl) ester, (α1R)-
CAS No.1252799-47-5

Synthetic Route by SureRoute

1. ACPHMB814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPHMB814 route product structure diagram
    ACPHMB8141252799-47-5
Inquiry

2. ACPHMB814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPHMB814 route product structure diagram
    ACPHMB8141252799-47-5
Inquiry

Comments (0)